Login
$GS
$892.01 +$0.47 (0.05%) After hours

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2026
As of Sep 30, 2026
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Assets
Cash and cash equivalents
Collateralized agreements
Securities purchased under agreements to resell (at fair value)
Securities borrowed (includes $60,397 and $51,581 at fair value)
Customer and other receivables (includes $374 and $315 at fair value)
Trading assets (at fair value and includes $204,612 and $158,641 pledged as collateral)
Investments (includes $103,509 and $75,767 at fair value)
Investments:
Available-for-sale securities (at fair value; amortized cost of $174,712 and $99,116)
Held-to-maturity securities
Other investments (includes $23,434 and $24,938 at fair value)
Loans (net of allowance of $2,310 and $2,148, and includes $4,586 and $4,905 at fair value)
Other assets (includes $179 and $180 at fair value)
Total assets
Liabilities and shareholders’ equity
Deposits (includes $89,157 and $76,569 at fair value)
Collateralized financings:
Securities sold under agreements to repurchase (at fair value)
Securities loaned (includes $13,821 and $11,995 at fair value)
Other secured financings (includes $33,111 and $27,833 at fair value)
Customer and other payables
Trading liabilities (at fair value)
Unsecured short-term borrowings (includes $80,742 and $59,758 at fair value)
Unsecured long-term borrowings (includes $143,897 and $112,683 at fair value)
Other liabilities (includes $267 and $111 at fair value)
Total liabilities
Shareholders’ equity
Preferred stock; aggregate liquidation preference of $14,778 and $15,153
Common stock; 936,363,922 and 931,995,446 shares issued, and 288,604,588 and 296,476,742 shares outstanding
Share-based awards
Nonvoting common stock; no shares issued and outstanding
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Stock held in treasury, at cost; 647,759,336 and 635,518,706 shares
Total shareholders’ equity
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support